Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

The clinical nurse specialist in uro-oncology is undervalued and underdeveloped, according to a discussion paper on the role of this clinician.

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...

Mural nominated two new development candidates, MURA-8518 a novel binding protein-resistant IL-18 with half-life extension, ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

Cuts to Medicare physician reimbursement have taken effect, as proposed legislation intended to eliminate those cuts did not pass.

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients ...

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial ...

Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 ...